Atlas Trials

Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

Clinical trial NCT00141765 · COMPLETED

Trial details

NCT number
NCT00141765
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Wilms TumorFibrosarcomaCarcinoma, Round CellNasopharyngeal CancerBrain Tumor, Recurrent
Start date
1997-01-01
Primary completion
2008-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.